158 related articles for article (PubMed ID: 20691260)
1. Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.
Master A; Wójcicka A; Piekiełko-Witkowska A; Bogusławska J; Popławski P; Tański Z; Darras VM; Williams GR; Nauman A
Biochim Biophys Acta; 2010 Nov; 1802(11):995-1005. PubMed ID: 20691260
[TBL] [Abstract][Full Text] [Related]
2. MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.
Boguslawska J; Wojcicka A; Piekielko-Witkowska A; Master A; Nauman A
PLoS One; 2011; 6(9):e24541. PubMed ID: 21912701
[TBL] [Abstract][Full Text] [Related]
3. Regulatory feedback loop between T3 and microRNAs in renal cancer.
Boguslawska J; Piekielko-Witkowska A; Wojcicka A; Kedzierska H; Poplawski P; Nauman A
Mol Cell Endocrinol; 2014 Mar; 384(1-2):61-70. PubMed ID: 24440748
[TBL] [Abstract][Full Text] [Related]
4. Multiple messenger ribonucleic acid variants regulate cell-specific expression of human thyroid hormone receptor beta1.
Frankton S; Harvey CB; Gleason LM; Fadel A; Williams GR
Mol Endocrinol; 2004 Jul; 18(7):1631-42. PubMed ID: 15105435
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of thyroid hormone receptor beta in renal cancer.
Wojcicka A; Piekielko-Witkowska A; Kedzierska H; Rybicka B; Poplawski P; Boguslawska J; Master A; Nauman A
PLoS One; 2014; 9(5):e97624. PubMed ID: 24849932
[TBL] [Abstract][Full Text] [Related]
6. A novel splice variant involving the 5' untranslated region of thyroid hormone receptor beta1 (TRbeta1).
Mannavola D; Moeller LC; Beck-Peccoz P; Persani L; Weiss RE; Refetoff S
J Endocrinol Invest; 2004 Apr; 27(4):318-22. PubMed ID: 15233549
[TBL] [Abstract][Full Text] [Related]
7. Lengthening of 3' Untranslated Regions of mRNAs by Alternative Polyadenylation Is Associated With Tumor Progression and Poor Prognosis of Clear Cell Renal Cell Carcinoma.
Zhang F; Chen L; Li W; Yang C; Xiong M; Zhou M; Kazobinka G; Zhao J; Hou T
Lab Invest; 2023 Jun; 103(6):100125. PubMed ID: 36889542
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
[TBL] [Abstract][Full Text] [Related]
9. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Gene-Specific Enhancement of Protein Translation by Targeting 5'UTRs of Selected Tumor Suppressors.
Master A; Wójcicka A; Giżewska K; Popławski P; Williams GR; Nauman A
PLoS One; 2016; 11(5):e0155359. PubMed ID: 27171412
[TBL] [Abstract][Full Text] [Related]
11. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels.
Silvestri E; Lombardi A; de Lange P; Schiavo L; Lanni A; Goglia F; Visser TJ; Moreno M
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1160-8. PubMed ID: 18430970
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase.
Yang YC; Lin YW; Lee WJ; Lai FR; Ho KH; Chu CY; Hua KT; Chen JQ; Tung MC; Hsiao M; Wen YC; Chien MH
J Biomed Sci; 2023 Aug; 30(1):68. PubMed ID: 37580757
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA.
Kwakkel J; Wiersinga WM; Boelen A
J Endocrinol; 2006 Apr; 189(1):37-44. PubMed ID: 16614379
[TBL] [Abstract][Full Text] [Related]
15. 3,5-di-iodothyronine stimulates tilapia growth through an alternate isoform of thyroid hormone receptor β1.
Navarrete-Ramírez P; Luna M; Valverde-R C; Orozco A
J Mol Endocrinol; 2014 Feb; 52(1):1-9. PubMed ID: 24031088
[TBL] [Abstract][Full Text] [Related]
16. T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.
Perri A; Catalano S; Bonofiglio D; Vizza D; Rovito D; Qi H; Aquila S; Panza S; Rizza P; Lanzino M; Andò S
Mol Cell Endocrinol; 2014 Jan; 382(1):205-217. PubMed ID: 24121026
[TBL] [Abstract][Full Text] [Related]
17. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
[TBL] [Abstract][Full Text] [Related]
18. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
